Skip to main content
. 2021 Oct 29;158:110722. doi: 10.1016/j.mehy.2021.110722

Fig. 1.

Fig. 1

Schematic outline of the hypothesis depicting how COVID-19 makes the patients susceptible to CAM and the restoration of melatonin deficiency in coronavirus patients protects them from the deadly menace [CAM → COVID-19 Associated Mucormycosis, GRP 78 → Glucose-Regulated Protein 78 (78 kDa molecular weight), ACE2 → Angiotensin-Converting Enzyme 2, SSRI → Selective Serotonin Reuptake Inhibitor, T-cell → Thymus-derived lymphocyte].